MedTrace Logo

ART-I02 in Patients With Rheumatoid Arthritis With Inflamed Wrists

NCT03445715 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2018-11-14

No results posted yet for this study

Summary

This study will evaluate the safety and tolerability of a single intra-articular administration of ART-I02 (AAV5.NF-kB.IFN-β), a recombinant adeno-associated virus (AAV) type 5 vector in subjects with RA and active arthritis of a wrist.

Conditions

Interventions

GENETIC

ART-I02

Single Intra-articular injection in the wrist joint

Sponsors & Collaborators

  • Arthrogen

    lead INDUSTRY

Principal Investigators

  • William O Martin, PhD · University Of Calagary

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-03
Primary Completion
2019-09-30
Completion
2020-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03445715 on ClinicalTrials.gov